SLV-324 Treatment of Metastatic Solid Tumors

NCT07108114 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Solid Tumors

Interventions

DRUG: SLV-324 intravenous (IV infusion)

Sponsor

Solve Therapeutics